The Application of Liuhedan Plaster in Postoperative Patients with Head and Neck Cancer

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500095542

Enrollment

Unknown

Registered

2025-01-08

Start date

2024-06-20

Completion date

Unknown

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Interventions

Liuhudan intervention group:external application of Liuhudan

control group:Normal post-operative care

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The pathological diagnosis of HNC is definitive, utilizing the 8th edition of the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC) TNM (tumor, node, metastasis) staging system; 2. Surgical treatment was performed during the hospitalization, and all surgical incisions were classified as Class II.

Exclusion criteria

Exclusion criteria: 1. Patients with an unclear diagnosis; 2. Patients allergic to Liuhedan Plaster or its ingredients; 3. Patients with concomitant trauma or other hard-to-heal wounds; 4. Patients or guardians who do not cooperate/refuse to participate in the study

Design outcomes

Primary

Measure	Time frame
Pain Score;Wound redness and swelling score;	—

Secondary

Measure	Time frame
Intensity of Antimicrobial Usage;Incidence of Adverse Events and Serious Adverse Events Related to External Application of Liuhedan;	—

Countries

China

Contacts

Public ContactLi Yuwen

West China Hospital, Sichuan University

liyuwenzs@163.com+86 189 8060 5906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026